Opinions & Interviews

Myasnikovich: Joint COVID-19 vaccine possible in EAEU

An archive photo

MOSCOW, 15 May (BelTA) – Cooperation between the member states of the Eurasian Economic Union (EAEU) in the pharmaceutical sector looks promising, including the possibility to develop a joint vaccine against COVID-19, Chairman of the Board of the Eurasian Economic Commission (ECC) Mikhail Myasnikovich said during the international videoconference forum “Assisting the Eurasian economic integration: the factor of business cooperation” on 15 May, BelTA has learned.

“As far as I am informed, the parties are now consulting on many issues and have great scientists and practitioners. I will once again look into this issue to see which institutions are involved in joint programs. We had an approach to the first biotechnology program. I think we will return to this topic. Vaccination issues are relevant,” Mikhail Myasnikovich said.

The chairman of the EEC Board pointed to the shortage of domestic medications on the EEC market. “Today we have a very poor market for medicines in general. Russia, Belarus and Kazakhstan buy huge volumes of both pharmaceutical substances and ready-made medicines for the needs of their markets - for hospitals and the population,” he said.

“We need to launch a large-scale program, perhaps even with the participation of producers from third countries. The scientific capacity in Russia is strong. Belarus can also boast good capacities and pilot production. We see our task in raising the topic and launching a large-scale joint program on drug manufacturing,” Mikhail Myasnikovich said.

print version

make home page

add to bookmarks